A 16-year-old boy presented with sudden vision loss, baffling doctors as his eye exams were normal. So what has really gone ...
image: The Food and Drug Administration has given Orphan Disease Designation and Rare Pediatric Disease Designation to OKN-007, an experimental brain cancer treatment currently in Phase 2 clinical ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio OKN-007 received FDA fast track ...